The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Short, full-dose neoadjuvant chemotherapy in localized high-risk adult soft tissue sarcomas (STS): An exploratory subgroup analysis on responding patients in a randomized controlled trial comparing 3 neoadjuvant versus 3 neoadjuvant + 2 adjuvant cycles of full dose anthracycline and ifosfamide chemotherapy at a 10yr median FU.
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bayer; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Sara Pizzamiglio
No Relationships to Disclose
 
Antonella Messina
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Paola Collini
No Relationships to Disclose
 
Antonio Llombart-Bosch
No Relationships to Disclose
 
Javier Martin Broto
Honoraria - Novartis
Consulting or Advisory Role - Bayer; Lilly; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - PharmaMar
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Alessandro Comandone
No Relationships to Disclose
 
Josefina Cruz
No Relationships to Disclose
 
Giovanni Grignani
Honoraria - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Bayer; Novartis; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Vittorio Quagliuolo
No Relationships to Disclose
 
Piero Picci
Honoraria - Amgen; Lilly
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Pharmamar; takeda
 
Antonino De Paoli
No Relationships to Disclose
 
Angelo Paolo Dei Tos
Speakers' Bureau - Lilly; Pfizer; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Paolo Verderio
No Relationships to Disclose
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - ARIAD/Merck; Bayer; Blueprint Medicines; Eisai; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; PharmaMar
Research Funding - Amgen/Dompé (Inst); Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MolMed (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Alessandro Gronchi
Honoraria - Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Lilly; Nanobiotix; Novartis; Pfizer; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - Nanobiotix; PharmaMar